Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Godefroid Charbon

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Clinical and Translational Gastroenterology|March 4, 2016
Secretion of Alpha-Hemolysin by Escherichia coli Disrupts Tight Junctions in Ulcerative Colitis PatientsHengameh Chloé Mirsepasi-Lauridsen, Zhengyu Du, Carsten Struve, et al.
Plos Genetics|January 28, 2017
Re-wiring of energy metabolism promotes viability during hyperreplication stress in E. coliGodefroid Charbon, Christopher Campion, Siu Hung Joshua Chan, et al.
Antibiotics (Basel, Switzerland)|October 27, 2022
Synergy between Mecillinam and Ceftazidime/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>Karoline Knudsen List, Mette Kolpen, Kasper Nørskov Kragh, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Clinical and Translational Gastroenterology|March 4, 2016
Secretion of Alpha-Hemolysin by Escherichia coli Disrupts Tight Junctions in Ulcerative Colitis PatientsHengameh Chloé Mirsepasi-Lauridsen, Zhengyu Du, Carsten Struve, et al.
Plos Genetics|January 28, 2017
Re-wiring of energy metabolism promotes viability during hyperreplication stress in E. coliGodefroid Charbon, Christopher Campion, Siu Hung Joshua Chan, et al.
Antibiotics (Basel, Switzerland)|October 27, 2022
Synergy between Mecillinam and Ceftazidime/Avibactam or Avibactam against Multi-Drug-Resistant Carbapenemase-Producing <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i>Karoline Knudsen List, Mette Kolpen, Kasper Nørskov Kragh, et al.
Pageof 4